Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article (34)

Advertisement

Free access | 10.1172/JCI108931

Interaction of Polymorphonuclear Neutrophils with Escherichia Coli: EFFECT OF ENTEROTOXIN ON PHAGOCYTOSIS, KILLING, CHEMOTAXIS, AND CYCLIC AMP

Mark J. Bergman, Richard L. Guerrant, Ferid Murad, Stephen H. Richardson, David Weaver, and Gerald L. Mandell

Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia 22901

Department of Microbiology, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27103

Department of Immunology, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27103

Find articles by Bergman, M. in: PubMed | Google Scholar

Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia 22901

Department of Microbiology, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27103

Department of Immunology, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27103

Find articles by Guerrant, R. in: PubMed | Google Scholar

Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia 22901

Department of Microbiology, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27103

Department of Immunology, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27103

Find articles by Murad, F. in: PubMed | Google Scholar

Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia 22901

Department of Microbiology, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27103

Department of Immunology, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27103

Find articles by Richardson, S. in: PubMed | Google Scholar

Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia 22901

Department of Microbiology, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27103

Department of Immunology, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27103

Find articles by Weaver, D. in: PubMed | Google Scholar

Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia 22901

Department of Microbiology, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27103

Department of Immunology, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27103

Find articles by Mandell, G. in: PubMed | Google Scholar

Published February 1, 1978 - More info

Published in Volume 61, Issue 2 on February 1, 1978
J Clin Invest. 1978;61(2):227–234. https://doi.org/10.1172/JCI108931.
© 1978 The American Society for Clinical Investigation
Published February 1, 1978 - Version history
View PDF
Abstract

Enterotoxigenic Escherichia coli are associated with noninflammatory diarrhea and stimulate adenylate cyclase activity of mammalian cells, thereby increasing intracellular cyclic adenosine 3′,5′-monophosphate (cyclic AMP). Increased concentrations of cyclic AMP in polymorphonuclear neutrophils (PMN) inhibit phagocytosis, candidacidal activity, granule discharge, and chemotactic responsiveness. We examined the effect of enterotoxin on the interaction of human PMN with E. coli. Enterotoxigenic and nonenterotoxigenic strains, including serotypes of E. coli identical except for the presence or absence of the plasmid coding for enterotoxin production, were utilized. Enterotoxigenic and nonenterotoxigenic E. coli, tumbled with PMN, were phagocytized and killed (>97%) equally well, and these strains stimulated PMN hexose monophosphate shunt activity equivalently.

However, a chemotaxis assay under agarose demonstrated that filtrates of 10 enterotoxigenic strains were less chemotactic for PMN by 15±2% total migration or 46±1% directed migration, when compared with 6 non-enterotoxigenic strains (P < 0.001). Inactivation of the enterotoxin by heat (65°C for 30 min) or antibodies formed to E. coli enterotoxin eliminated the inhibitory effect of the enterotoxic filtrates for PMN chemotaxis. Addition of purified E. coli enterotoxin directly to the PMN decreased chemotaxis to E. coli filtrates by 32±2% (P < 0.001). These data suggest that the effect was due to the heat-labile enterotoxin. The phosphodiesterase inhibitor, 1-methyl-3-isobutylxanthine (0.1 mM), which potentiates effects due to an increase in intracellular cyclic AMP, further decreased total PMN migration (random plus directed) toward enterotoxic filtrates to 46% of that to nonenterotoxic filtrates (P < 0.001). Addition of cholera toxin (1 μg/ml), which is similar to E. coli enterotoxin, to the PMN inhibited total migration toward nonenterotoxic filtrates by 16±2% (P < 0.001). Exogenous dibutyryl cyclic AMP (2 mM) inhibited total PMN migration toward E. coli filtrates by 32% (P < 0.001). PMN intracellular cyclic AMP levels increased by 220% after 2 h of incubation with purified E. coli enterotoxin. The decreased chemotactic attractiveness of enterotoxic E. coli filtrates appears to be related to the ability of enterotoxin to increase cyclic AMP in PMN. Enterotoxin production by E. coli may be advantageous to the microbe by decreasing its chemotactic appeal for PMN.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 227
page 227
icon of scanned page 228
page 228
icon of scanned page 229
page 229
icon of scanned page 230
page 230
icon of scanned page 231
page 231
icon of scanned page 232
page 232
icon of scanned page 233
page 233
icon of scanned page 234
page 234
Version history
  • Version 1 (February 1, 1978): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article (34)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts